PRELUDE CAPITAL MANAGEMENT, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1387508 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,390,538

-$441,522 QoQ

Shares Held

2,345

-37.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	154,970	$4,667,696
2	ETON	Eton Pharmaceuticals, Inc.	188,802	$4,659,633
3	CRON	Cronos Group Inc.	1,500,000	$3,765,000
4	LQDA	Liquidia Corp	40,595	$1,532,055
5	UTHR	UNITED THERAPEUTICS Corp This page	2,345	$1,390,538
6	VTRS	Viatris Inc	102,186	$1,380,532
7	PCRX	Pacira BioSciences, Inc.	50,735	$1,146,611
8	ALKS	Alkermes plc.	16,928	$598,574

All Filings in UTHR

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,390,538	2,345	-37.6%	Shares	Other	2026-05-15
2025-12-31	$1,832,060	3,760	+33.6%	Shares	Other	2026-02-17
2025-09-30	$1,179,656	2,814	-56.1%	Shares	Other	2025-11-14
2023-09-30	$1,448,956	6,415	-80.9%	Shares	Other	2023-11-14
2021-06-30	$6,034,455	33,635	+49.7%	Shares	Sole	2021-08-16
2021-03-31	$3,759,393	22,475	+2.8%	Shares	Other	2021-05-17
2020-12-31	$3,318,129	21,860	+2436.0%	Shares	Other	2021-02-16
2020-09-30	$87,062	862	-79.4%	Shares	Other	2020-11-16
2020-06-30	$505,780	4,180	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.